Skip to content
Review

BioPROTACs: a promising approach for targeted protein degradation.

Sep 2026 · Acta Pharmacologica Sinica · 0 citations · 33 references
Medicine

TL;DR

The molecular mechanisms, recent advances, and emerging applications of bioPROTAC technology are summarized, the current technical challenges are evaluated, potential strategies to address these limitations are discussed, and future directions that may facilitate its clinical translation are highlighted.

View source

Similar papers

Review Sep 2026

Expanding the E3 Ligase Landscape: From Small Molecule to Biological Targeted Protein Degradation.

This review summarizes the development of classical small-molecule E3 ligase ligands and highlights emerging biological recruitment strategies involving antibodies, nanobodies, aptamers, peptides, and engineered proteins that provide greater programmability and selectivity.

Xuan Zhao, Yu-Han Liu, Xu-Cong Teng · 0 citations
Review Open access Aug 2026

PROTAC-Based Strategies in Neurodegenerative Diseases: Challenges and Perspectives

This review summarizes recent advances in chemical protein degradation strategies for neurodegenerative disorders and highlights potential future perspectives of multifunctional PROTACs for therapeutic development.

Pasquale Degennaro, Imane Ghafir El Idrissi, Rosa Purgatorio et al. · 0 citations
Review Open access Sep 2026

Proteolysis targeting chimeras for drug discovery from mechanistic basis to clinical translation

Advances establish PROTAC technology as a transformative platform in modern drug discovery while emphasizing the scientific and translational challenges that must be addressed to enable broader clinical application.

Sandip Badadhe, Vikas B. Gawali, Mahesh D. Bhalsing et al. · 0 citations
Sep 2026

The Delivery Strategies for PROTAC.

This chapter systematically examines three progressive tiers of PROTAC delivery using stimuli-activatable moieties, and highlights how these strategies achieve spatiotemporally controlled, tumor-selective protein degradation while minimizing off-tumor toxicity.

Yi-Jing Dang, Ze-Li Long, Jing Gao et al. · 0 citations
Aug 2026

Post-translational chemical modification of E3 ligase for efficient target protein degradation.

This work reports the first ligand-directed chemical strategy that converts transient PROTAC-mediated ternary complex formation into binary target recognition via post-translational chemical modification of an E3 ligase, and believes it could provide a platform for next-generation targeted protein degraders to overcome...

Eunbin Park, Jinjoo Jung, G. J. Kumar et al. · 0 citations
Review Open access Sep 2026

Hydrophobic Tag Protein Degraders: An Emerging Therapeutic Strategy for Cancer

Gaining deeper mechanistic insight into the nature of HyT degradation will be essential to further the potential of HyTDs as powerful tools in cancer research and therapeutics.

Tania Aguilera-Pineda, Siddhartha Kumar, Gargi Ghosal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.